bromocriptine has been researched along with MPTP Neurotoxicity Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghumatkar, PJ; Jain, PD; Patil, SP; Sancheti, JS; Sathaye, S; Tambe, R | 1 |
| Chacun, H; Farinotti, R; Fernandez, C; Lacomblez, L; Milane, A; Vautier, S | 1 |
| Mohanasundari, M; Sabesan, M; Sethupathy, S; Srinivasan, MS | 1 |
| Krupina, NA; Kryzhanovskiĭ, GN; Orlova, IN | 1 |
| Bédard, PJ; Di Paolo, T; Gagnon, C; Gomez-Mancilla, B; Markstein, R | 1 |
| Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N | 1 |
| Fukuzaki, K; Kamenosono, T; Kitazumi, K; Nagata, R | 1 |
| Bédard, PJ; Di Paolo, T; Rouillard, C | 1 |
8 other study(ies) available for bromocriptine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice.
Topics: Animals; Apigenin; Brain-Derived Neurotrophic Factor; Bromocriptine; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Luteolin; Male; Mice; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Pars Compacta; Random Allocation; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2014 |
Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Blotting, Western; Brain; Bromocriptine; Disease Models, Animal; Gene Expression Regulation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease; Tissue Distribution | 2009 |
Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Ataxia; Bromocriptine; Catalase; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Glutathione; Glutathione Peroxidase; Hand Strength; Hypericum; Lipid Peroxidation; Locomotion; Male; Mice; MPTP Poisoning; Muscle Weakness; Neuroprotective Agents; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Superoxide Dismutase | 2006 |
[The effect of parlodel on development of depressive syndrome in rats, caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Depressive Disorder; Disease Models, Animal; Dopamine Agonists; Drinking Behavior; Male; MPTP Poisoning; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1995 |
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.
Topics: Animals; Autoradiography; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine Agents; Dopamine Agonists; Female; Indoles; Macaca fascicularis; MPTP Poisoning; Neostriatum; Ovariectomy; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1995 |
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination | 1998 |
Effects of ropinirole on motor behavior in MPTP-treated common marmosets.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Agonists; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2000 |
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone | 1990 |